Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

32.16
-1.7000-5.02%
Post-market: 32.300.1400+0.44%19:57 EDT
Volume:2.38M
Turnover:77.36M
Market Cap:3.75B
PE:-6.89
High:33.86
Open:33.75
Low:31.98
Close:33.86
52wk High:43.15
52wk Low:22.96
Shares:116.65M
Float Shares:110.00M
Volume Ratio:1.37
T/O Rate:2.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6676
EPS(LYR):-3.1920
ROE:-88.85%
ROA:-51.86%
PB:9.19
PE(LYR):-10.08

Loading ...

Jul 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2026

Major Issues Report

Form 8-K - Current report
Jul 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 29, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 26, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 30, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 30, 2026

Major Issues Report

Form 8-K - Current report
Feb 11, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2026

Major Issues Report

Form 8-K - Current report
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 23, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]